213 related articles for article (PubMed ID: 10534934)
1. [Successful pregnancy after conservative surgery and chemotherapy for dysgerminoma of the ovary: case report].
Studziński Z; Kaliński S; Filipczak A; Branicka D
Ginekol Pol; 1999 Aug; 70(8):553-7. PubMed ID: 10534934
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant chemotherapy in dysgerminoma].
Fechtig A; de Dycker RP; Schumacher T; Neumann RL
Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
4. Dysgerminoma: the role of conservative surgery.
Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
6. [Pure dysgerminoma of the ovary. 12 case reports].
Kdous M; Hachicha R; Gamoudi A; Boussen H; Benna F; Rahal K
Tunis Med; 2003 Dec; 81(12):937-43. PubMed ID: 14986529
[TBL] [Abstract][Full Text] [Related]
7. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
8. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
Zhang R; Hong W; Li S
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
[TBL] [Abstract][Full Text] [Related]
9. Conservative surgical staging as a means to preserve fertility in patients with dysgerminoma: a case report.
Maidarti M; Garinasih PD; Anggraeni TD
Ann Med Surg (Lond); 2023 Mar; 85(3):427-430. PubMed ID: 36923762
[TBL] [Abstract][Full Text] [Related]
10. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
11. Pure dysgerminoma of the ovary: a review of 45 well staged cases.
Ayhan A; Bildirici I; Günalp S; Yuce K
Eur J Gynaecol Oncol; 2000; 21(1):98-101. PubMed ID: 10726633
[TBL] [Abstract][Full Text] [Related]
12. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
Jeyakumar A; Cabeza R; Hindenburg A
Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
[TBL] [Abstract][Full Text] [Related]
13. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
[TBL] [Abstract][Full Text] [Related]
14. [Ovarian dysgerminoma in children and adolescents. Retrospective clinico-pathologic study].
Zuntová A; Sumerauer D; Teslík L; Koutecký J
Cas Lek Cesk; 2004; 143(4):246-52. PubMed ID: 15218724
[TBL] [Abstract][Full Text] [Related]
15. [Dysgerminoma of the ovary. Presentation of case report].
Mihaylova I; Parvanova V; Kostova P
Akush Ginekol (Sofiia); 2013; 52(2):56-9. PubMed ID: 23807982
[TBL] [Abstract][Full Text] [Related]
16. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
17. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with chemotherapy of the malignant tumor of germinal cells (dysgerminoma) of the ovary].
Ramírez Torres N; Basavilvazo Rodríguez MA; Téllez Márquez A; Robles Robles G; Lemus Rocha R; Hernández Valencia M
Ginecol Obstet Mex; 2004 Oct; 72():500-7. PubMed ID: 15790190
[TBL] [Abstract][Full Text] [Related]
19. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.
Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Gerbaulet A; Droz JP
Gynecol Oncol; 1995 Sep; 58(3):344-8. PubMed ID: 7672699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
